[ Price : $8.95]
FDAs annual report on drug approvals says the majority of novel drugs approved in 2025 moved through accelerated regulatory pathwa...[ Price : $8.95]
Advocacy groups urge Congress to advance legislation that would eliminate the statutory distinction between biosimilars and so-cal...[ Price : $8.95]
Sanofi says its experimental antibody amlitelimab showed consistent efficacy and a favorable safety profile across multiple late-s...[ Price : $8.95]
FDA approves Guardant Healths Guardant360 CDx liquid biopsy as a companion diagnostic to identify patients with BRAF V600Emutant m...[ Price : $8.95]
FDA releases the form FDA-483 with 10 observations from an inspection at Japans Sato Pharmaceutical over-the-counter drug manufact...[ Price : $8.95]
FDA issues an early alert warning of a potentially high-risk issue involving certain wound and burn dressings made by Integra Life...[ Price : $8.95]
FDA grants Opna Bio an orphan drug designation for its investigational treatment OPN-2853 (zavabresib) for treating myelofibrosis.[ Price : $8.95]
A United States Pharmacopoeia study finds that protective purchasing following information on drug shortages can adversely affect ...